# Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Organization · id `cardio:org-chia-tai-tianqing-pharmaceutical-group-co-ltd` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov sponsor names](<https://clinicaltrials.gov/search?spons=Chia+Tai+Tianqing+Pharmaceutical+Group+Co.%2C+Ltd.>), retrieved 18 November 2026. No person wrote or checked this page.

## In plain language

An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 3 trials in this atlas.

## Technical summary

Sponsor class industry. No ROR record matches the name exactly.

## The registry's words

- Sponsor name: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Sponsor class: INDUSTRY

## Connected pages

- Sponsors: Study of TQ-F3083 Capsules in Subjects With Type 2 Diabetes Mellitus (`cardio:ct-nct03986073`)
- Sponsors: Study to Assess the Efficacy and Safety of Liraglutide in the Treatment of Type 2 Diabetes (`cardio:ct-nct04373967`)
- Sponsors: A Clinical Study of Insulin Degludec Injection in Subjects With Type 2 Diabetes (`cardio:ct-nct04955834`)

## Provenance

Content hash: 0e9c3dbf8a5c5dd1517e2fbaf613142c07e3780ee3f4ddfb3142c966ee443627
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
